arrow
N

Natasha Honoré

universite catholique louvain
H指数:6
被引数:163

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tumour-agnostic plasma assay for circulating tumour DNA predicts outcome in recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with a PD-1 inhibitor

循环肿瘤DNA的肿瘤不可知血浆测定可预测用PD-1抑制剂治疗的头颈部复发和/或转移性鳞状细胞癌的结果

2023-12-010
PRE
Tumor-agnostic plasma assay for circulating tumor DNA detects minimal residual disease and predicts outcome in locally advanced squamous cell carcinoma of the head and neck

循环肿瘤DNA的肿瘤不可知血浆测定可检测微小残留疾病并预测头颈部局部晚期鳞状细胞癌的预后

2023-12-0115
OA
Minimal residual disease (MRD) diagnosed by a plasma tumor-agnostic circulating tumor DNA (ctDNA) assay after curative therapy in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN) predicts disease relapse and survival
2023-10-010
OA
Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study
2021-05-209
OAAI